Article
IDH-mutated astrocytomas with 19q-loss constitute a subgroup that confers better prognosis.
Cancer science - 1 Jul 2018
Otani Ryohei, Uzuka Takeo, Higuchi Fumi, Matsuda Hadzki, Nomura Masashi, Tanaka Shota, Mukasa Akitake, Ichimura Koichi, Kim Phyo, Ueki Keisuke
Abstract excerpt
IDH-mutant gliomas are classified into astrocytic or oligodendroglial tumors by 1p/19q status in the WHO 2016 classification, with the latter presenting with characteristic morphology and better prognosis in general. However, the morphological and genetic features within each category are varied, and there might be distinguishable subtypes. We analyzed 170 WHO grade II-IV gliomas resected in our institution....
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
